📰 Resented News
Page 12 - Resented News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.
May 16, 2023
An historic premiere. Significant anniversaries and, in some cases, a final concert for several members of the orchestra. An orchestra program featuring…
May 13, 2023
Mumbai, May 12: Transovative, a leading provider of technology solutions, has been awarded the Global Excellence Award for Most Innovative Field Management Apps. The award was presented by Bollywood star Madhuri Dixit at a recent ceremony in Mumbai, India.
May 12, 2023
Hundreds of high school students learned about the vital ideas and perspectives women bring to STEM fields at an annual event presented by CommBank and Telstra. When was the first female crash test... | May 12, 2023
May 12, 2023
DZ Bank has raised its fair value for KWS Saat from 75 to 76 euros after detailed figures for the first nine months and left its rating at buy. In a study presented on Friday, DZ Bank analyst Axel... | May 12, 2023
May 11, 2023
Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus. lactis strain Plasma*1 , researched and developed by Kirin Holdings Company,... | May 11, 2023
May 11, 2023
May 11, 2023 Late-breaking data presented from largest-ever randomized controlled multicenter clinical trial on optimizing patient safety during coronary proceduresPhilips-hosted symposiums and... | May 11, 2023
May 11, 2023
RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive Impairment Associated with Schizophrenia.GRX-917: Presented PD data from the completed Phase 1 study, which suggest the... | May 11, 2023
May 11, 2023
Data Will Also Be Presented in a Poster Session at the American Society of Clinical Oncology Annual Meeting on June 3, 2023 SOUTH SAN FRANCISCO, Calif., May 11, 2023 -- Allogene Therapeutics,... | May 11, 2023
May 11, 2023
Poster presentation will highlight durable, long-term responses in relapsed/refractory DLBCL patients treated with ZYNLONTA ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2
May 11, 2023
Presented initial preclinical data from ETX-123, Eliems lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed mechanism of action on neuronal excitability ... | May 11, 2023